DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more
▼ + stars: | 2024-07-08 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.

Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead

☆ Eli Lilly shares have plenty room to run even after hitting a new high on Monday
▼ + stars: | 2024-07-08 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Shares of the iPhone maker hit a new high after the opening. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Morgan Stanley, Wells, Eli Lilly, Joe Biden, Lilly's donanemab, Jim Cramer's Organizations: CNBC, Microsoft, Apple, Palo Alto Networks, Facebook, Palo, Bulls, Bears Locations: Palo, Palo Alto

☆ Mounjaro leads to significantly more weight loss than Ozempic, study suggests
▼ + stars: | 2024-07-08 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +4 min

CNN —People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. But 82% of people taking tirzepatide reached this important clinical benchmark, compared with about 67% of those taking semaglutide. Average weight loss was also consistently higher among those taking tirzepatide over time. And by one year, average weight loss was nearly double for those taking tirzepatide — more than 11%, compared with about 6% for those taking semaglutide. According to the new study, individuals with type 2 diabetes had less significant weight loss than those without a diagnosis — but average weight loss was still greater among those taking tirzepatide.

Persons: tirzepatide, Eli Lilly, ”, Dr, Sanjay Gupta, CNN’s Brenda Goodman Organizations: CNN, US Food and Drug Administration, Novo Nordisk, semaglutide, FDA, CNN Health Locations: Truveta

☆ Stop worrying and learn to love the triumph of Big Tech over everything
▼ + stars: | 2024-07-07 | by ( Jim Cramer | ) www.cnbc.com time to read: +9 min

We don't say they have a secular wind at their backs. We don't say: Apple's business is much better than we thought. They keep coming back to one main point: You can't have these companies dominate without something bad happening to the stock market. Let me present a different, factual manifesto: The companies with these amazing gains are companies that just don't stop inventing. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Eli Lilly, Joe Biden, Biden, Lilly, —, Tesla, Elon Musk, Jim Cramer's, Jim Cramer, Jim Organizations: Amazon, Microsoft, Apple, Nvidia, Nasdaq, pharma, Novo Nordisk, National Football League, YouTube, Web Services, Costco, Walmart, Jim Cramer's Charitable, CNBC, Facebook, Google Locations: Lilly

☆ This ETF is trying to satisfy appetites for weight loss stocks
▼ + stars: | 2024-07-06 | by ( Ellie Stevens | ) www.cnbc.com time to read: 1 min

Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. The firm's founder and CEO Maurits Pot thinks the winning weight loss trade isn't based on just hype. "We could see a world where the majority of the world's population takes a GLP-1, not just for weight loss, but for other diseases." His top holdings include Mounjaro manufacturer Eli Lilly and Ozempic and Wegovy maker Novo Nordisk. Eli Lilly is up 57% so far this year, while Novo Nordisk is up 38%.

Persons: Maurits Pot, Pot, Eli Lilly, Ozempic Organizations: Cardiometabolic, Novo Nordisk Locations: Tema, Novo

☆ Investors want proof AI will aid drug discovery. Evidence may come in the second half
▼ + stars: | 2024-07-06 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +10 min

Analysts who have been following companies on the cutting edge of using generative AI for drug discovery say it is still very early days. But these endorsements haven't lifted Recursion shares out of a slump. RXRX 1Y mountain Recursion shares over the past year. The drug company will be a beta user of Recursion's LOWE (Large Language Model-Orchestrated Workflow Engine) and the pair are also partnering on oncology research. SDGR 1Y mountain Schrodinger shares over the past year.

Persons: Scott Schoenhaus, Chris Gibson, Jensen Huang, Leerink, Mani Foroohar, Foroohar, Recursion's, KeyBanc's Schoenhaus, Needham, Gil Blum, it's, Recursion's LOWE, Blum, Eli Lilly, AbCellera, KeyBanc's, Schoenhaus, FactSet, Allison Bratzel, Piper Sandler, Goldman Sachs, Salveen Richter, Peter Lawson, Lawson, Japan's Takeda, Schrodinger, Leerink's Foroohar Organizations: Analysts, Capital, Nvidia, ARK Investment Management, REC, CCM, Union, Bayer, Therapeutics, Dynamo, RLY, Barclays, Japan's Locations: U.S, biopharma, Biohive

☆ Top 5 things to watch in the stock market Friday, including big jobs report
▼ + stars: | 2024-07-05 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

The June employment report on Friday morning came in slightly better than expected with the economy adding 206,000 nonfarm jobs versus 200,000 expected. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. Top things to watch Friday, July 5Stocks were mixed slightly Friday following another record S&P 500 th holiday. The June employment report on Friday morning came in slightly better than expected with the economy adding 206,000 nonfarm jobs versus 200,000 expected.

Persons: Eli Lilly, Jefferies, Jim Cramer's, Jim Cramer, Jim, Constellation Brands Novo Nordisk Eli Lilly Samsung Organizations: Treasury, Constellation Brands, JPMorgan, Novo Nordisk, Samsung Electronics, Jim Cramer's Charitable, CNBC, Constellation Brands Novo Nordisk, Constellation Brands Novo Nordisk Eli Lilly Samsung Electronics

☆ Parenting influencers in Illinois must now pay their children if they feature in videos. Experts say it's about time.
▼ + stars: | 2024-07-05 | by ( Lindsay Dodgson | ) www.businessinsider.com time to read: +7 min

Read previewA new law passed in Illinois on July 1 requires parenting influencers to set aside 15% of their earnings for their kids who appear on camera. But, there is a market for family content because it gets good engagement, Varbanova added. "If people stopped watching family content, family vloggers wouldn't exist." Because family content is so successful, it's also tough to give it up. Advertisement"If they appear in all of the videos, they should get at least 50% of the revenue," Varbanova said.

Persons: —, Shreya Nallamothu, Jessica Maddox, Naomi Cahn, Katya Varbanova, shouldn't, Varbanova, influencer Jordan, Lilly Davis, Paul, Momfluencer Ruby Franke, Ruby Franke, Wren, Jacquelyn Paul, TikTok, it's Organizations: Service, YouTube, Business, Associated Press, University of Alabama, AP, The New York Times, University of Virginia's Family Law, School of Law, UVA, Disney Locations: Illinois, Washington , Maryland, California

☆ Gina Gershon on Her Best Movie Roles: 'Bound,' 'Showgirls,' 'Killer Joe'
▼ + stars: | 2024-07-05 | by ( Caralynn Matassa | ) www.businessinsider.com time to read: +15 min

On defying her agents to star in 'Bound' and finding Corky's look in San Francisco lesbian barsJennifer Tilly and Gina Gershon in "Bound." I was hesitant to take on any role coming off of "Showgirls," just because, honestly, I was pretty burnt out. When the script for "Bound" was sent to us, my agents were pretty clear saying, "Listen, you are not doing this movie. On her 'Showgirls' PTSD and why she's come around on the movieGina Gershon in "Showgirls." I'm really into it."

Persons: Gina Gershon, —, It's, Gershon, Louie, who's, she's, Paul Verhoeven's, Corky, Jennifer Tilly's femme, Violet, Jennifer Tilly, Lana, Lilly Wachowski, They've, I've, Susie Bright, Jennifer, Tilly, Susie, couldn't, I'm, Let's, Elizabeth Berkley's, Lili Anolik, Paul, Verhoeven, Chekhov, I'd, That's, you've, she'd, Matthew McConaughey, Joe, Matthew McConaughey's, Tracy Letts, William Friedkin, Billy wasn't, Billy, Matthew, Nicolas Cage, Nicolas, John Woo …, John Woo, Nick Cassavetes, John, Jason Guerrasio, Cate Blanchett, Jamie Lee Curtis, Kevin Hart Organizations: Business, Pride, LD Locations: San Francisco

☆ Wall Street firm gets it right with Best Buy call, plus Eli Lilly shares move up
▼ + stars: | 2024-07-03 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Davidson analysts touted Best Buy stock on Wednesday, listing artificial-intelligence-enabled PCs as a positive catalyst for the electronics retailer. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, Jeff Marks, Davidson, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, New York Stock Exchange, Independence, Food and Drug Administration, Jefferies Locations: U.S, D.A

☆ Stocks making the biggest moves premarket: Paramount, Tesla, Constellation Brands and more
▼ + stars: | 2024-07-03 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Tesla — The electric vehicle maker rose nearly 3% , a day after posting stronger-than-expected delivery numbers for the second quarter. Shares popped 10% during Tuesday's session. Constellation Brands — The beer and wine stock rose more than 2% after a better-than-expected earnings report. Southwest Airlines — Shares were fractionally lower after the airline carrier announced it had adopted a shareholder rights plan. Shares dipped about 1% during Tuesday's session.

Persons: Tesla, LSEG, Eli Lilly, — CNBC's Lisa Han, Jesse Pound, Sarah Min Organizations: Paramount, Paramount Global, Skydance Media, The New York Times, Wall Street Journal, Constellation Brands, Constellation, Southwest Airlines —, Elliott Investment Management, Food and Drug Administration, MGM Resorts, MGM Resorts International

☆ FDA approves a new Alzheimer's drug from Eli Lilly
▼ + stars: | 2024-07-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFDA approves a new Alzheimer's drug from Eli LillyEvan Seigerman, BMO Capital Markets senior research analyst, joins 'Squawk Box' to discuss the FDA's approval of Eli Lilly's Alzheimer's drug donanemab, how much revenue it could add to Elil LIlly's bottom line, and the details behind the newly approved drug.

Persons: Eli Lilly Evan Seigerman, Eli Lilly's Organizations: FDA, BMO Capital Markets

☆ 10 things to watch in the stock market Wednesday after the S&P 500's record close
▼ + stars: | 2024-07-03 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Loops Capital raised its price target for off-price retailer TJX to $125 from $115. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating. Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating.

Persons: Tuesday's, depletions, Jefferies, Eli Lilly, Lululemon, Baird, BTIG, Dell, Amphenol, Jim Cramer's, Jim Cramer, Jim, John Thys Organizations: Constellation Brands, Pepsico, Cowen, Nike, MGM Resorts, Bank of America's, Jim Cramer's Charitable, CNBC, AFP, Getty Locations: Zeebrugge, Belgium

☆ This fund manager beating the market is betting AI stocks like Micron will outperform again in second half
▼ + stars: | 2024-07-03 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

The second half of the year is underway, and investor Andrew Graham thinks technology stocks will continue to lead the market higher. Investors have debated whether technology stocks can sustain their lofty gains, or if the market rally is due to broaden. The investor likes semiconductor names such as Nvidia and Micron , which he said should benefit from the ongoing memory cycle. MU YTD mountain MU year to date Outside of tech, Graham favors industrials, which are adjacent to the AI theme. The portfolio manager also has positions in NextEra Energy , which he thinks is primed to capitalize on AI.

Persons: Andrew Graham, Graham, —, industrials, that's, Eli Lilly, Capital's Organizations: Nvidia, Investors, Jackson, Capital, CNBC, Micron, MU, Arista, Dell, Arm Holdings, Broadcom, NextEra Energy Locations: Eaton, Graham, U.S

☆ FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
▼ + stars: | 2024-07-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. The Food and Drug Administration on Tuesday approved Eli Lilly 's Alzheimer's drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The agency approved the treatment, which will be sold under the brand name Kisunla, for adults with early symptomatic Alzheimer's disease, according to the company. "Having multiple treatment options is the kind of advancement we've all been waiting for — all of us who have been touched, even blindsided, by this difficult and devastating disease." It's a long-awaited win for Eli Lilly after donanemab faced obstacles in its path to market.

Persons: Eli Lilly, Joanne Pike, donanemab Organizations: Company, The, Drug Administration, U.S, Alzheimer's Association, FDA Locations: Indianapolis , Indiana, U.S

☆ Microsoft and Eli Lilly are among the most overbought stocks as the first half ends
▼ + stars: | 2024-06-28 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Shares of Microsoft registered a 14-day RSI reading of 74. MSFT YTD mountain MSFT YTD Shares of Eli Lilly are also overbought, with a 14-day RSI of 83, putting the drug manufacturer at the top of the list. FedEx is also overbought, with a 14-day RSI of 77. Among the oversold names, Walgreens Boots Alliance and Waters Corporation top the list with a 14-day RSI reading of 20, followed by Pool Corp . with an RSI reading of 22.

Persons: Friday's, Wall, Eli Lilly, Eli Lilly's Organizations: Dow Jones, Nasdaq, Nvidia, Microsoft, CNBC Pro, Union, FedEx, Walgreens Boots Alliance, Waters Corporation, Pool Corp, Walgreens

☆ Eli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise Chen
▼ + stars: | 2024-06-27 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise ChenLouise Chen, Cantor Fitzgerald analyst, joins CNBC's 'Squawk Box' to discuss Eli Lilly's surge over the past year, manufacturing, and more.

Persons: Eli Lilly, Louise Chen Louise Chen, Cantor Fitzgerald, Eli Lilly's Organizations: Novo Nordisk

Here's a rapid-fire update on all 33 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Best Buy : Jim said Best Buy's pullback in recent days has created a buying opportunity in the electronics retailer. Salesforce : The stock has in recent weeks clawed back some of its post-earnings plunge , even before Thursday's 6% surge. Wynn Resorts : Wynn is another stock in the portfolio that, it's become increasingly clear, trades based on its exposure to China. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Jim, Wall, Abbott, Johnson, We're, haven't, it's, Walt Disney, Estee Lauder, levered, Eli Lilly, Lilly, Morgan Stanley, Goldman Sachs, OpenAI, Jensen Huang, Nikesh Arora's, Stanley Black, Decker, TJX, We've, Wells, Charlie Scharf poaches, Wynn, Jim Cramer, Michael M Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Apple, Abbott Laboratories, Prime, Web, Broadcom, VMWare, Costco Wholesale, Costco, Coterra Energy, DuPont, Walt, Disney, Nvidia, Ford Motor, Ford, Blue, Motors, GE Healthcare, GE, Management, Honeywell, Linde, Microsoft, Palo Alto Networks, Procter & Gamble, Constellation Brands, Modelo, Corona, Fed, TJX, JPMorgan, Wynn Resorts, Wynn, Jim Cramer's Charitable, Traders, New York Stock Exchange, Santiago, Getty Locations: China, Covid, Dover, Eaton, Palo Alto, U.S, Wells Fargo, Las Vegas

☆ These are the most expensive S&P 500 stocks heading into the second half
▼ + stars: | 2024-06-27 | by ( Brian Evans | ) www.cnbc.com time to read: +4 min

Artificial Intelligence plays Top AI plays were among the list of expensive stocks in the S & P 500, including Broadcom , Lam Research , Intel and Super Micro Computer . Each stock's price-earnings ratio equates to a roughly 60% to 66% premium over the historical average. SMCI YTD mountain Super Micro Computer stock. Super Micro Computer, meanwhile, has continued to ride the AI wave despite some weakness last month after third-quarter revenue missed analyst expectations. The stock's trailing 12-month price-earnings ratio is also more than double its five-year average, at a 63% premium.

Persons: Elon Musk, Daron Acemoglu, Goldman Sachs, Eli Lilly Eli Lilly, Eli Lilly, Biogen's Leqembi Organizations: CNBC Pro, Nvidia, CNBC, Stock, Artificial Intelligence, Broadcom, Lam Research, Intel, Micro, Super Micro Computer, Computer, Wall, Bank of America, Micro Computer, Dell, Massachusetts Institute of Technology, U.S . Food, Drug Administration Locations: U.S

☆ A Gen Zer who moved to Indianapolis, where she pays less than $1,700 in rent, shares the pros of living in 'a big city with small-town charm.'
▼ + stars: | 2024-06-27 | by ( Madison Hoff | ) www.businessinsider.com time to read: +7 min

She also resided in New York City, and she has studied abroad and worked in Italy. Now working and living in Indianapolis, Ball doesn't see herself leaving this Midwest city soon. With a population of over 800,000, Ball finds Indianapolis is "a big city with small-town charm." "There was just something really charming about the city," Ball said. Courtesy of Milan BallShe does miss getting around via subway in New York City and finds it tough not having a car to get around in Indianapolis.

Persons: —, she's, Ball, Zers, Indiana University Lilly, I'm, didn't, Ball's, Milan Organizations: Service, Business, Midwest Ball, Indianapolis, Indiana University, Indiana University Lilly Family School of Philanthropy, Innovation, Public Locations: Indianapolis, Virginia, New York City, Italy, Midwest, New York, Washington, DC, York, Williamsburg, White

The iShares U.S. Pharmaceuticals ETF (IHE) is up 9% since July 2015, when it hit a fresh all-time high. All of the back-and-forth movement since 2015 has produced what could be a monstrous bullish pattern. But we're trying to capture a major breakout from an area that's done next to nothing in nearly a decade. INVA, on the other hand, bottomed in March 2023, and just recently broke out of a large inverse head & shoulders pattern. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.

Persons: IHE, Eli Lilly, Johnson, JNJ, MRK, Frank Cappelleri Organizations: U.S . Pharmaceuticals, IHE, Merck, CNBC, NBC UNIVERSAL Locations: U.S, LLY

☆ DuPont draws suitors for its water unit, plus what's driving Eli Lilly's bounce
▼ + stars: | 2024-06-25 | by ( Morgan Chittum | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer argued that the market's been too focused on the AI darling. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Eli Lilly, Novo Nordisk's Wegovy, Mounjaro, Ozempic, Jim Cramer's Organizations: CNBC, Nasdaq, Nvidia, DuPont, Bloomberg, Novo Nordisk's, Club Locations: China, LLY

☆ Novo Nordisk's Wegovy weight loss drug approved in China
▼ + stars: | 2024-06-25 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +2 min

Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world's second largest economy. China's National Medical Products Administration "recently" approved the weekly injectable drug, Novo Nordisk said in a press release on the Chinese version of its website, according to Google translate. Novo Nordisk did not immediately respond to CNBC's request for further information on the proposed pricing and rollout timeline of the drugs. The company's Ozempic diabetes drug was approved in 2021 and saw sales in the greater China region double last year. On Monday, Novo Nordisk announced it is investing $4.1 billion to expand its manufacturing in the U.S.

Persons: —, Eli Lilly Organizations: Novo Nordisk, Medical Products Administration, Google, Reuters, National Health Commission, U.S Locations: China, Danish, London, Clayton , North Carolina

☆ Jim Cramer's top picks for pet-centric stocks
▼ + stars: | 2024-06-25 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

As some of the market's hottest stocks take a pause, CNBC's Jim Cramer on Tuesday told investors it may be wise to get into some "slowdown stocks," like companies with products related to pets. Cramer suggested the "post-Covid drought" in these stocks could be over and pinpointed three: online retailer Chewy , animal health care company Elanco and J.M. Smucker, which owns pet food brands alongside its namesake jelly products and snacks for people. Smucker's efforts to trim down its pet food portfolio. "I'm going with Smucker because of its distinctive shrink-to-grow-more-profitably lucrative narrative in pet food," he said.

Persons: Jim Cramer, Cramer, Eli Lilly, Elanco, J.M, Smucker

☆ Cramer's Lightning Round: 'I would not abandon' Cava
▼ + stars: | 2024-06-24 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Viking Therapeutics' year-to-date stock performance. Stock Chart Icon Stock chart icon Cava's year-to-date stock performance. Stock Chart Icon Stock chart icon Rubrik's year-to-date stock performance. Stock Chart Icon Stock chart icon Forward Air's year-to-date stock performance. Stock Chart Icon Stock chart icon Bristol Myers Squibb's year-to-date stock performance.

Persons: Lilly, Bristol Myers, Meyers, Jim Cramer's Organizations: Therapeutics, Viking Therapeutics, Forward, Bristol Myers Squibb

Search resuls for: "lilly"

25 mentions found